David George Kelly's most recent trade in Iterum Therapeutics Plc was a trade of 647,059 Share Option (Right to Buy) done . Disclosure was reported to the exchange on June 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Iterum Therapeutics Plc | David George Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 647,059 | 647,059 | - | - | Share Option (Right to Buy) | |
| Iterum Therapeutics Plc | David George Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 64,706 | 64,706 | - | - | Stock Option (Right to Buy) |